ESMO Asia 2026

Name: ESMO Asia 2026
Start: 2026-12-04
End: 2026-12-06
Location: Suntec Convention Centre

ESMO Asia 2026 takes place on 4–6 December 2026 at Suntec Convention Centre, Singapore. It is organised by European Society for Medical Oncology (ESMO), and B2DB lists 307 speakers and 91 sessions announced so far.

The ESMO Asia Congress 2026 takes place from 4 to 6 December 2026 in Singapore. The Congress brings together oncology professionals, researchers and healthcare providers from across the Asia-Pacific region and beyond to advance cancer research, improve clinical practice and enhance patient care. The scientific and educational programme covers precision oncology, immunotherapy, multidisciplinary cancer care, supportive care and emerging therapeutic strategies across tumour types, with dedicated sessions on the ESMO Pan-Asian Guidelines Adaptation (PAGA) and activities for Young Oncologists.

Key facts

Dates	4–6 December 2026 (upcoming)
Venue	Suntec Convention Centre, Singapore, Singapore
Organiser	European Society for Medical Oncology (ESMO)
Series	ESMO Asia
Speakers	307
Sessions	91
Stages	Hall 406, Room 310, Room 325, Hall 405, Hall 404 Discussion hub, Nicoll 1, Hall 401, Hall 407, Hall 402, Gastrointestinal Tumours, Upper Digestive, Gynaecological Cancers, Developmental Therapeutics, Breast Cancer, Metastatic, Basic Science and Translational Research, Genitourinary Tumours, Prostate, Penile and Testis, Poster area (Exhibition), NSCLC, Metastatic, Gastrointestinal Tumours, Lower Digestive
Sponsors	3
Official site	esmo.org/meeting-calendar/esmo-asia-congress-2026/programme

Keynote speakers

Peng-Hui Wang Taipei Veterans General Hospital
Tomohiro Matsuda NCCH - National Cancer Center Hospital-Tsukiji Campus

Speakers (307)

Compiled from the published agenda; speakers can claim and verify their own entry.

Junya Fukuoka Nagasaki University Hospital
Humaid O. Al-Shamsi Burjeel Medical City
Ravindran Kanesvaran NCCS - National Cancer Centre Singapore
Ben Tran Peter MacCallum Cancer Centre
Herbert Ho Fung Loong The Chinese University of Hong Kong - Prince of Wales Hospital
Yoon-Sim Yap NCCS - National Cancer Centre Singapore
Carla Van Herpen Radboud University Medical Centre Nijmegen
Paula G. Franco
Daniel Shao Weng Tan NCCS - National Cancer Centre Singapore
Jung-Yun Lee Yonsei Cancer Center and Severance Hospital, Yonsei University College of Medicine
Stephen L. Chan The Chinese University of Hong Kong - Prince of Wales Hospital
Sung-Bae Kim Asan Medical Center, University of Ulsan College of Medicine
Yao Zhu Fudan University Shanghai Cancer Center
Do-Youn Oh Seoul National University Hospital
Elisa Fontana Sarah Cannon Research Institute SCRI UK
Jia Jenny Liu St Vincent's Hospital Sydney
Myung-Ju Ahn Hanyang University College of Medicine
Kohei Shitara National Cancer Center Hospital East
Sun Young Rha Severance Hospital - Yonsei University College of Medicine
Antonio Calles Blanco Hospital General Universitario Gregorio Maranon
Aya El-Helali HKU - The University of Hong Kong
Ben Solomon Peter MacCallum Cancer Center
Choong-kun Lee Yonsei Cancer Center Yonsei University
Elena Castro Marcos Hospital Universitario 12 de Octubre
Hongcheng Zhu
Prudence Francis Peter MacCallum Cancer Center
Sanjay Popat The Royal Marsden Hospital - Chelsea
Alison C. Tree The Royal Marsden Hospital (Sutton)
Brigette B. Ma The Chinese University of Hong Kong - Sino Building
Caroline Even Institut Gustave Roussy
Christopher J Sweeney The University of Adelaide
Evandro De Azambuja
Filippo Pietrantonio Fondazione IRCCS Istituto Nazionale dei Tumori
Iwona Lugowska Maria Sklodowska-Curie National Research Institute of Oncology
Jyoti Bajpai Apollo Hospitals, Navi Mumbai
Lavinia Spain Peter MacCallum Cancer Center
Lu Xie Peking University People's Hospital
Ming Chun Poon The Chinese University of Hong Kong - Prince of Wales Hospital
Naomi Kiyota Kobe University Hospital
Rebecca A. Dent NCCS - National Cancer Centre Singapore
Rebecca Kristeleit Guy's Hospital
Ross A. Soo National University Cancer Institute Singapore
Sara De Dosso EOC - Ospedale Regionale Bellinzona e Valli - Istituto Oncologico della Svizzera Italiana (IOSI)
Solange Peters CHUV - Centre Hospitalier Universitaire Vaudois
Stefanie Zschäbitz NCT - Nationales Zentrum für Tumorerkrankungen
Su Pin Choo NCCS - National Cancer Centre Singapore
Sun Min Lim Yonsei Cancer Center Yonsei University
Anne Letsch Universitätsklinikum Schleswig Holstein Campus Kiel II
Byoung Chul Cho Severance Hospital - Yonsei University College of Medicine
Christina H. Ruhlmann OUH - Odense University Hospital
Christophe Le Tourneau Institut Gustave Roussy
Daphne Day Monash Health - Monash Medical Centre
Dirk Schadendorf WTZ - Westdeutsches Tumorzentrum Essen
Eiji Kikuchi St. Marianna University School of Medicine Yokohama City Seibu Hospital
Elizabeth Smyth ESMO Director of Education, Oxford University Hospitals NHS Foundation Trust
Enrico Franceschi IRCCS Istituto delle Scienze Neurologiche di Bologna
Eva Blondeaux IRCCS Ospedale Policlinico San Martino
Hee Kyung Ahn Samsung Medical Center (SMC)
Hideaki Bando National Cancer Center Hospital East
Hui Gan Austin Health - Austin Hospital
Hyo Song Kim Korea Cancer Center Hospital
Jacqueline Ho Sze Lee Hong Kong Baptist Hospital
Janice Wing-Hang Tsang School of Clinical Medicine, The University of Hong Kong
Jaya Ghosh Tata Memorial Hospital
Jayne E. Wood The Royal Marsden Hospital - Chelsea
Jenny Seligmann The University of Leeds
Jin-Ji Yang The Second Affiliated Hospital of Guangzhou Medical University
Jun Zhou Peking University Cancer Hospital & Institute
Junko Tanizaki Kindai University - Faculty of Medicine
Karim Fizazi
Lorenza Rimassa IRCCS Humanitas Research Hospital
Lu Si Peking University Cancer Hospital & Institute
Mariana Brandão Institute Jules Bordet
Mary Antonette G. Ong Antique Medical Center, Inc.
Masanori Mori Seirei Mikatahara General Hospital
Matthew Chau Hsien Ng NCCS - National Cancer Centre Singapore
Matthias Guckenberger
Mei-Kim Ang NCCS - National Cancer Centre Singapore
Nuttapong Ngamphaiboon Mahidol University - Faculty of Medicine Ramathibodi Hospital
Paolo A. Ascierto National Cancer Institute IRCCS, Fondazione G. Pascale Naples
Qijun Du Pamela Youde Nethersole Eastern Hospital
Raymond Han Lip Ng
Rienk Offringa DKFZ - German Cancer Research Center
Sarah Derks Amsterdam UMC - Vrije University Medical Centre (VUmc)
Seema Gulia Homi Bhabha Cancer Hospital and Research Centre
Shubham Pant
Sung Yong Oh Dong-A University College of Medicine
Valentina Boni
Vanita Noronha Tata Memorial Hospital
Victor H. Lee The University of Hong Kong - Li Ka Shing Faculty of Medicine
Wan Zamaniah Wan Ishak University Malaya Medical Centre
Wei Peng Yong NUHS - National University Health System
Jeanne Tie Medical Oncologist, Peter MacCallum Cancer Centre
Julien Vibert Institut Gustave Roussy
Maria Alice Franzoi Gustave Roussy - Cancer Campus
Adar Yaacov Shaare Zedek Medical Center
Pei Li Stephanie Saw NCCS - National Cancer Centre Singapore
Kosei Hasegawa Saitama Medical University International Medical Center
Alfredo Addeo HUG - Hopitaux Universitaires de Geneve
Benoit You Hospices Civils de Lyon - Hopital Lyon Sud
Caicun Zhou Shanghai Pulmonary Hospital, Tongji University
David Tai NCCS - National Cancer Centre Singapore
Eileen Y. Poon NCCS - National Cancer Centre Singapore
Juan Li Army Specialty Medical Center of PLA
Ning Li Chinese Academy of Medical Science - National Cancer Center, Cancer Hospital
Nobuaki Matsubara National Cancer Center Hospital East
Paolo Bossi IRCCS Humanitas Research Hospital
Peng-Hui Wang Taipei Veterans General Hospital
Samuel X. Stevens Illawarra Cancer Care Centre
Sharlene Gill BC Cancer Agency - Vancouver
Shinji Ohno Sagara Hospital
Tomohiro Matsuda NCCH - National Cancer Center Hospital-Tsukiji Campus
Xiaoyong Huang Zhongshan Hospital, Fudan University
Ya Hwee Tan NCCS - National Cancer Centre Singapore
Yi-Long Wu Guangdong Province People's
Ming-Huang Chen Taipei Veterans General Hospital
Muh-Hwa Yang Taipei Veterans General Hospital
Yoland Antill The Royal Melbourne Hospital
Abhishikha Abhishikha AIIMS - All India Institute of Medical Sciences
Aiping Zhou Chinese Academy of Medical Sciences
Alessandra Gennari Università Degli Studi Del Piemonte Orientale Amedeo Avogadro - Scuola di Medicina
Amit Rauthan Manipal Comprehensive Cancer Center Manipal Hospital
Angela Lamarca Hospital Universitario Fundacion Jimenez Diaz
Anthony Joshua The Kinghorn Cancer Centre
Anwen Xiong
Apostolia Maria Tsimberidou University of Texas, MD Anderson Cancer Center
Ashish Gulia Homi Bhabha Cancer Hospital And Research Centre New Chandigarh
Ava Kwong The University of Hong Kong - Li Ka Shing Faculty of Medicine
Bipinesh Sansar MPMMCC & HBCH, Tata Memorial Centre
Bo Hyun Kim
Boon Chua Prince of Wales Hospital - Nelune Comprehensive Cancer Centre
Brian Nicholson University of Oxford
Bruno G. Sangro
Bryan C. Li The University of Hong Kong - Queen Mary Hospital
Byoung-Gie Kim Samsung Medical Center (SMC)
Changhoon Yoo Asan Medical Center - University of Ulsan
Chen Haige Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Chen Liu Peking University Cancer Hospital
Chieh-Ni J. Kao Kaohsiung Medical University Chung-Ho Memorial Hospital
Chiun-Sheng Huang
Deborah Mukherji Clemenceau Medical Center
Derek De-Rui Huang NTUCC - National Taiwan University Cancer Center
Dingwei Ye Fudan University Cancer
Dion Forstner St Vincent's Hospital Sydney
Divya Gandrala Basavatarakam Indo American Cancer Hospital & Research Institute
Edmund Chiong NUH - National University Hospital (S) Pte. Ltd.
Els Van Nieuwenhuysen UZ Leuven - University Hospitals Leuven - Campus Gasthuisberg
Emi Noguchi Pharmaceuticals and Medical Devices Agency
Emilie Le Rhun University Hospital Zürich
Eun Ji Nam Yonsei University College of Medicine
Georgina V. Long Melanoma Institute Australia
Gilles Freyer Hospices Civils de Lyon - Hôpital Lyon Sud
Giuseppe Luigi Banna Queen Alexandra Hospital
Go Ikeda Showa University Hospital
Goutham G. Katta Charu Danja Healthcare Private Limited
Gregory A. Vidal West Cancer Center and Research Institute
Hai-Qiang Mai Sun Yat-Sen University Cancer Center
Hanmei Lou Cancer Hospital of the University of Chinese Academy of Sciences/ Zhejiang Cancer Hospital
Hemant Malhotra MGMCH - Mahatma Gandhi Medical College & Hospital
Herdee Gloriane Luna National Kidney and Transplant Institute
Huiching Wang Kaohsiung Medical University Chung-Ho Memorial Hospital
Humera Mahmood AECH - Atomic Energy Cancer Hospital - NORI
Hye Ryun Kim Yonsei Cancer Center Yonsei University
Hyehyun Jeong Asan Medical Center - University of Ulsan
Hyun-woong Cho Asan Medical Center - University of Ulsan
Ilya Tsimafeyeu STOONCO Clinic
Ines E. Pires da Silva Fundação Champalimaud
Inkeun Park Asan Medical Center - University of Ulsan
Jacob Sands Dana Farber Cancer Institute
Jacqueline V. Aredo Mass General Brigham Cancer Institute, Harvard Medical School
James Chih-Hsin Yang National Taiwan University Hospital
Jayesh Desai Peter MacCallum Cancer Centre
Jeannette Ting Wen Ching CUHK - Chinese University of Hong Kong
Jeeyun Lee Samsung Medical Center (SMC) - Sungkyunkwan University School of Medicine
Jia Zhong CAMS-PUMC - Chinese Academy of Medical Sciences and Peking Union Medical College - Dongdan Campus
Jialong Song Chinese PLA General Hospital (301 Military Hospital)
Jian Zhang Fudan University Shanghai Cancer Center
Jiangnan Duan Tangdu hospital, The Fourth Military Medical University
Jianjun J. Zhang The University of Texas MD Anderson Cancer Center
Jianye Wang Qilu Hospital of Shandong University
Jie Lan Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jie Tang Hunan Cancer Hospital
Joycelyn J. Lee NCCS - National Cancer Centre Singapore
Julia Rotow The Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute
Jumpei Yoshida The Cancer Institute Hospital of Japanese Foundation for Cancer Research (JFCR)
Jun Yu Tianjin Medical University Cancer Institute and Hospital
Junichiro Watanabe Juntendo University Graduate School of Medicine
Junyong Dai Chongqing University Cancer Hospital
Kaewta Jeerapradit Mahidol University - Faculty of Medicine Ramathibodi Hospital
Kan Yonemori NCCH - National Cancer Center Hospital-Tsukiji Campus
Kanwal Raghav The M.D. Anderson Cancer Center
Karen Howarth SAGA Diagnostics AB
Kartik Sehgal Dana-Farber Cancer Institute
Katarina Rejlekova National Cancer Institute of Slovakia
Kavya Ronanki AIIMS - All India Institute of Medical Science Rishikesh
Ke Sai Sun Yat-Sen University Cancer Center
Ken Kato NCCH - National Cancer Center Hospital-Tsukiji Campus
Kevin L. Chua NCCS - National Cancer Centre Singapore
Kimiora Henare University of Auckland Faculty of Medical & Health Sciences
Kumar Prabhash Tata Memorial Hospital
Kumarakulasinghe Barr Nesaretnam NCIS - National University Cancer Institute Singapore
Kyung H. Jung Asan Medical Center, University of Ulsan College of Medicine
Li Zhang Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Provincial Clinical Research Centre for Cancer
Lili Mao Peking University Cancer Hospital & Institute
Lingfang Xia Fudan University Shanghai Cancer Center
Lisa G. Horvath Chris O'Brien Lifehouse
Long L. Chan The Chinese University of Hong Kong, Department of Clinical Oncology
Manabu Kinoshita AMU - Asahikawa Medical University Hospital
Manuela Schmidinger MedUni Wien - Medical University of Vienna
Marion Subklewe LMU Klinikum der Universität München
Masatoshi Kudo Kindai University Faculty of Medicine
Mastura Md Yusof Hospital Picaso
Matilda Lee NCIS - National University Cancer Institute Singapore
Ming Kuang The First Affiliated Hospital of Sun Yat-sen University
Mitchell Elliott Yale School of Medicine
Molly Li The Chinese University of Hong Kong - Prince of Wales Hospital
Mostafa A. Sumon Kurmitola General Hospital
Myung Ah Lee The Catholic University of Korea
Najib Ben Khaled LMU Klinikum der Universität München
Nam H. Dang Vietnam National Cancer Hospital
Nirmala Bhoo-Pathy UMMC - University Malaya Medical Centre
Nobuhiro Hanai Aichi Cancer Center Hospital
Oliver Klein Monash University
Omshree Shetty
Paul A. Cohen University of Western Australia
Pei-Hsing Chen National Taiwan University Hospital
Pei-jye Voon Sarawak General Hospital
Peter R. Galle University Medical Center
Petros Christopoulos Thoraxklinik Heidelberg gGmbH
Po-Huang Chen National Taiwan University Hospital
Pongwut Danchaivijitr Faculty of Medicine Siriraj Hospital
Qi-Tong Zhang Sun Yat-Sen University Cancer Center
Rasha Cosman St Vincent's Hospital Sydney
Rishika Goyal Chadha Kidwai Memorial Institute of Oncology
Roberto F. Salgado GZA Ziekenhuizen Campus Sint-Augustinus
Robin L. Jones The Royal Marsden Hospital - Chelsea
Rong Zheng Fujian Medical University Union Hospital
Rongbo Lin Fujian Cancer Hospital and Fujian Medical University Cancer Hospital
Ruyun Gao
Sabina Sangaletti Fondazione IRCCS - Istituto Nazionale dei Tumori
Sabrina Croce BERGONIE
Salah-Eddin Al-Batran KHNW - Krankenhaus Nordwest GmbH
Sandip Basu RMC - Radiation Medicine Centre - B.A.R.C.
Se Hoon Park Samsung Medical Center, Sungkyunkwan University School of Medicine
Seigo Katakura Kanagawa Cancer Center
Serene S. Goh National University Hospital (NUH)
Shahneen K. Sandhu Peter MacCallum Cancer Centre
Shaodong Hong Sun Yat-Sen University Cancer Center
Sherilyn Liew NCCS - National Cancer Centre Singapore
Shun Lu Shanghai Chest Hospital, Shanghai Jiao Tong University
Sin Ting Chan BC Cancer Agency - Surrey
Sohei Satoi Kansai Medical University
Sophia Yien Ning Wong NCCS - National Cancer Centre Singapore
Stefano Fanti AOU Policlinico S. Orsola-Malpighi , Nuclear Medicine
Sufang Qiu Fujian Cancer Hospital and Fujian Medical University Cancer Hospital
Sung Yong Lee Korea University Guro Hospital
Surein Arulananda Monash Health - Monash Medical Centre
Sushma Bhatnagar Indraprastha Apollo Hospital
Syed Adnan Ali Australian National University
Sze Wai Chan Sandton Oncology
Tak W. Mak UHN - University Health Network - Princess Margaret Cancer Centre
Takayuki Ueno The Cancer Institute Hospital of Japanese Foundation for Cancer Research (JFCR)
Tatsunori Shimoi NCCH - National Cancer Center Hospital-Tsukiji Campus
Teresa M. Amaral Institut public de Cancérologie Strauss Europe (Institut Strauss)
Thomas B. Powles St. Bartholomew's Hospital
Timothy Anthony Yap MD Anderson Cancer Center
Tom Wei-Wu Chen NTU - National Taiwan University - College of Medicine
Tony K. Lim
Toshio Shimizu Kansai Medical University
Ullas Batra Rajiv Gandhi Cancer Institute and Research Centre
Valerie Huei Li Gan SGH - Singapore General Hospital
Wee-Joo Chng NUS - National University of Singapore
Weijian Guo Fudan University Shanghai Cancer Center
Wen Xu Princess Alexandra Hospital - Metro South Health
Wen Zhang Chinese Academy of Medical Sciences
Wenyan Chen The Third Hospital of Nanchang
William Nassib William Junior Grupo Oncoclinicas
Winnie Lam SGH - Singapore General Hospital
Xiaorong Dong Huazhong University of Science and Technology
Ximei Zhang Tianjin Cancer Hospital
Yasuhiro Nakamura Saitama Medical University International Medical Center
Ye Guo Shanghai East Hospital, School of Medicine, Tongji University
Yejin Kim National Cancer Center Graduate School of Cancer Science and Policy
Yi-Hsin Liang NTUH - National Taiwan University Hospital
Ying Fan Peking University First Hospital
Ying Yuan The Second Affiliated Hospital of Zhejiang University College of Medicine
Yongning Jia Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute
Yuan Peng National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Yuan Wang The Second Affiliated Hospital of Air Force Medical University/Tangdu Hospital
Yuan-Kai Shi National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Yuanyuan Zhao Sun Yat-sen University Cancer Center
Yukinori Ozaki The Cancer Institute Hospital of Japanese Foundation for Cancer Research (JFCR)
Yunze Xu Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Yupeng Hong Zhejiang Provincial People's Hospital
Yuping Sun Shandong Cancer Hospital
Zhifeng Shi Fudan University
Ziming Li Shanghai Chest Hospital, Shanghai Jiao Tong University
Aaron Tan Chia-Ken NCCS - National Cancer Centre Singapore
Chelsia Sim
Delvys Rodriguez-Abreu Complejo Hospitalario Universitario Insular
Hidetoshi Hayashi Kindai University - Faculty of Medicine
Hope S. Rugo City of Hope Comprehensive Cancer Center
Jack J. Chan NCCS - National Cancer Centre Singapore
Jonathan W. Riess UC Davis Comprehensive Cancer Center
Kenneth J. O'Byrne Princess Alexandra Hospital - Metro South Health
Lucksamon Thamlikitkul Mahidol University - Faculty of Medicine
Po-Hsiang Huang National Taiwan University Hospital

Most represented companies

NCCS - National Cancer Centre Singapore — 17 speakers
Sun Yat-Sen University Cancer Center — 5 speakers
Asan Medical Center - University of Ulsan — 4 speakers
Fudan University Shanghai Cancer Center — 4 speakers
National Taiwan University Hospital — 4 speakers
NCCH - National Cancer Center Hospital-Tsukiji Campus — 4 speakers
The Chinese University of Hong Kong - Prince of Wales Hospital — 4 speakers
Institut Gustave Roussy — 3 speakers
National Cancer Center Hospital East — 3 speakers
Peking University Cancer Hospital & Institute — 3 speakers

Agenda (91 sessions)

Day 1 — Friday 4 December 2026

ESMO Asia Congress 2026 - Opening session 09:30–10:30 · Hall 406 — Tomohiro Matsuda
Optimising delivery of care: Working the science, managing toxicity and improving access 10:45–12:15 · Room 310 — Sandip Basu, Stefano Fanti, Winnie Lam
Rationalising immunotherapy 10:45–12:15 · Room 325 — Byoung Chul Cho, Sabina Sangaletti, Wen Xu
RAS targeting in GI tumours 10:45–12:15 · Hall 405 — Elisa Fontana, Filippo Pietrantonio, Su Pin Choo, Jayesh Desai
Proffered Paper session: Thoracic malignancies 10:45–12:05 · Hall 406 — Herbert Ho Fung Loong, Antonio Calles Blanco, Vanita Noronha, Caicun Zhou +3 more
Decoding diversity: Genomic alterations shaping prostate cancer in Asian men 10:45–11:30 · Hall 404 Discussion hub — Elena Castro Marcos, Shahneen K. Sandhu
Organisation of care and referral policies in the APAC region 10:45–12:15 · Nicoll 1 — Ravindran Kanesvaran, Karim Fizazi, Eileen Y. Poon, Samuel X. Stevens +2 more
Proffered Paper session: Breast cancer 10:45–12:15 · Hall 401 — Prudence Francis, Rebecca A. Dent, Shinji Ohno, Chiun-Sheng Huang +3 more
Overcoming resistance and improving tolerability for patients with ovarian cancer 10:45–12:15 · Hall 407 — Jung-Yun Lee, Rebecca Kristeleit, Kosei Hasegawa
Proffered Paper session: Developmental therapeutics and precision medicine 10:45–12:15 · Hall 402 — Ben Tran, Iwona Lugowska, David Tai, Xiaoyong Huang +5 more
Amgen, Inc - Reimagining immunotherapy in mAPMR prostate cancer: Current evidence and future opportunities for T-cell engaging strategies 12:30–14:00 · Hall 406 — Ravindran Kanesvaran, Ben Tran, Nobuaki Matsubara, Lisa G. Horvath
MSD - The Now, the Future and the How in the management of advanced endometrial cancer 12:30–14:00 · Gastrointestinal Tumours, Upper Digestive — Kosei Hasegawa, Yoland Antill, Chelsia Sim, Jack J. Chan
AbbVie - The evolution of treatment for platinum resistant ovarian cancer 12:30–14:00 · Gynaecological Cancers — Byoung-Gie Kim
Astellas Pharma - Evolving practice in advanced gastric cancer: Biomarker-guided therapy and emerging perspectives in HER2 negative disease 12:30–14:00 · Hall 407 — Kohei Shitara, Sun Young Rha, Matthew Chau Hsien Ng, Ming-Huang Chen
AstraZeneca - Navigating the evolving 1L landscape in metastatic breast cancer: Emerging evidence and clinical implications across subtypes 12:30–14:00 · Hall 402 — Rebecca A. Dent, Amit Rauthan, Mastura Md Yusof
Revolution Medicines - Advancing RAS-targeted treatment paradigms: Clinical insights and future opportunities in lung and GI cancers 12:30–14:00 · Developmental Therapeutics — Su Pin Choo, Shubham Pant, Changhoon Yoo
Medscape Global Oncology - Shaping the future of HER2-mutated advanced NSCLC: Precision strategies across the continuum 12:30–14:00 · Breast Cancer, Metastatic — Herbert Ho Fung Loong, Daniel Shao Weng Tan, Hye Ryun Kim
Rapid Oral session: Genitourinary tumours 14:15–15:45 · Hall 402 — Yao Zhu, Qijun Du, Juan Li, Chen Haige +6 more
Kill that pain! 14:15–15:00 · Hall 404 Discussion hub — Raymond Han Lip Ng, Sushma Bhatnagar
Proffered Paper session: Gynaecological cancers 14:15–15:45 · Hall 407 — Jung-Yun Lee, Kosei Hasegawa, Benoit You, Eun Ji Nam +4 more
Perioperative immunotherapy in locally advanced HNSCC: Practice-changing or still experimental? 14:15–15:45 · Room 310 — Carla Van Herpen, Caroline Even, Nuttapong Ngamphaiboon, Nobuhiro Hanai
Proffered Paper session: Gastrointestinal tumours 14:15–15:35 · Hall 406 — Stephen L. Chan, Jenny Seligmann, Ning Li, Jeeyun Lee +3 more
The new wave of therapeutic innovation in NSCLC 14:15–15:45 · Hall 405 — Sun Min Lim, Mariana Brandão, Alfredo Addeo, Pei-jye Voon
Changes to trial design to deliver patient benefit 14:15–15:45 · Room 325 — Timothy Anthony Yap, Toshio Shimizu
The best treatment sequencing of metastatic breast cancer 14:15–15:45 · Hall 401 — Yoon-Sim Yap, Sung-Bae Kim, Prudence Francis, Alessandra Gennari
Daiichi Sankyo Co., Ltd. - Navigating the evolving treatment landscape in EGFR-mutated NSCLC 16:00–17:00 · Hall 401 — Myung-Ju Ahn, Pei Li Stephanie Saw, James Chih-Hsin Yang
Abbott - MCEDS: Redefining the early detection of cancers 16:00–17:00 · Basic Science and Translational Research — Brian Nicholson, Chieh-Ni J. Kao
YO Mentorship session 1 16:00–16:30 · Hall 404 Discussion hub — Paula G. Franco, Jia Jenny Liu, Filippo Pietrantonio, Alfredo Addeo
Roche - Following cancer over time: Ultra-sensitive MRD in early disease and ctDNA monitoring in advanced stages 16:00–17:00 · Room 325 — Aya El-Helali, Karen Howarth, Mitchell Elliott, Surein Arulananda
ESMO Colloquium supported by Astellas - The rapidly evolving landscape of urothelial cancer: Insights in biology and therapy 16:00–17:00 · Room 310 — Ravindran Kanesvaran, Stefanie Zschäbitz, Eiji Kikuchi, Inkeun Park
AstraZeneca - Navigating the next era of hepatobiliary management: Expert perspectives and case-based discussion 16:00–17:00 · Basic Science and Translational Research — Lorenza Rimassa, David Tai, Bo Hyun Kim, Bruno G. Sangro
Roche Products - Evidence in action: Navigating treatment in 1L metastatic breast cancer 16:00–17:00 · Hall 402 — Yoon-Sim Yap, Po-Hsiang Huang
Pfizer - Defining precision in mCSPC (mAPMN/S): The clinical impact of PARPi+ARPi combinations 16:00–17:00 · Genitourinary Tumours, Prostate, Penile and Testis — Yao Zhu, Elena Castro Marcos, Nobuaki Matsubara
Poster Display session and cocktail 17:15–18:15 · Poster area (Exhibition)

Day 2 — Saturday 5 December 2026

Controversies in the management of platinum resistance at first ovarian cancer relapse 09:00–09:45 · Hall 404 Discussion hub — Jie Tang
Immunotherapy in brain tumours 09:00–10:30 · Room 325 — Lavinia Spain, Enrico Franceschi, Emilie Le Rhun, Ke Sai +1 more
Proffered Paper session: Genitourinary tumours 09:00–10:20 · Hall 407 — Yao Zhu, Ming Chun Poon, Dingwei Ye, Pongwut Danchaivijitr +3 more
Hot topics in the management of early breast cancer 09:00–10:30 · Hall 401 — Yoon-Sim Yap, Ava Kwong, Boon Chua, Hyehyun Jeong +2 more
Rapid Oral session: Thoracic malignancies 09:00–10:30 · Hall 406 — Daniel Shao Weng Tan, Ben Solomon, Sanjay Popat, Solange Peters +7 more
Rapid Oral session: Gastrointestinal tumours 09:00–10:30 · Hall 405 — Choong-kun Lee, Jun Zhou, Sarah Derks, Go Ikeda +8 more
Integration of supportive care with emerging new therapeutic strategies 09:00–10:30 · Room 310 — Jayne E. Wood, Masanori Mori, Maria Alice Franzoi, Kumarakulasinghe Barr Nesaretnam
Rapid Oral session: Head and neck cancer 09:30–10:25 · Hall 402 — Carla Van Herpen, Victor H. Lee, Kaewta Jeerapradit, Qi-Tong Zhang +3 more
ESMO 2026 Highlights session I 10:45–12:25 · Hall 406 — Do-Youn Oh, Myung-Ju Ahn, Kohei Shitara, Ross A. Soo +4 more
ESMO 2026 Highlights session II 10:45–12:15 · Hall 405 — Christopher J Sweeney, Lu Xie, Peng-Hui Wang, Deborah Mukherji +3 more
Pfizer - The CROWN trial at 7 years: Durable disease control redefines patient care towards chronic management 12:45–14:15 · Hall 401 — Ben Solomon, Petros Christopoulos, Ullas Batra, Ziming Li
YO Vesalius talk - Future-proofing your oncology career: What is the value of training in AI, precision oncology, clinical trial participation, leadership development? 12:45–13:15 · Hall 404 Discussion hub — Paula G. Franco, Hongcheng Zhu, Evandro De Azambuja, Sara De Dosso
MSD - Translating emerging evidence into practice: Optimizing immunotherapy strategies across metastatic and early-Stage NSCLC 12:45–14:15 · NSCLC, Metastatic — Sun Min Lim, Aaron Tan Chia-Ken, Delvys Rodriguez-Abreu
AstraZeneca - Transforming the treatment journey: Personalized care in EGFR-mutated, MET- and HER2-altered NSCLC 12:45–14:15 · NSCLC, Metastatic — Ross A. Soo, Pei Li Stephanie Saw, Yi-Long Wu, Julia Rotow +1 more
Merck Healthcare KGaA - State of the art management of mCRC in APAC: Recent developments and future outlooks 12:45–14:15 · Hall 405 — Brigette B. Ma, Jeanne Tie, Yi-Hsin Liang
Bristol Myers Squibb - Redefining the treatment paradigm for non-small cell lung cancer (NSCLC): Innovations on the horizon 12:45–14:15 · Room 310 — Solange Peters, Hidetoshi Hayashi, Kenneth J. O'Byrne
Johnson & Johnson Innovative Medicine - Pipeline with purpose: Maximizing the impact of J&J's transformational medicines in clinical practice 12:45–14:15 · Hall 402 — Ben Tran, Herbert Ho Fung Loong, Muh-Hwa Yang
PeerView Oncology - Precision-guided interventions in HER2+ GI tumors: Expert perspectives on operationalizing the latest evidence on antibody–drug conjugates for advanced disease 12:45–13:45 · Room 325 — Do-Youn Oh, Sun Young Rha, Kanwal Raghav
AI in oncology: Potential and healthcare integration 14:30–16:00 · Room 325 — Junya Fukuoka, Janice Wing-Hang Tsang, Julien Vibert, Serene S. Goh
Head and neck cancers in Asia 14:30–16:00 · Room 310 — Paolo Bossi, Humera Mahmood, Kumar Prabhash, Mostafa A. Sumon
Rapid Oral session: Breast cancer 14:30–15:45 · Hall 401 — Sung-Bae Kim, Eva Blondeaux, Hee Kyung Ahn, Adar Yaacov +5 more
Endometrial cancer: Practical decisions in the molecular and immunotherapy era 14:30–16:00 · Hall 402 — Rebecca Kristeleit, Benoit You, Yoland Antill, Els Van Nieuwenhuysen
Capitalising on emerging breakthroughs in non-metastatic pancreatic cancer 14:30–16:00 · Hall 407 — Stephen L. Chan, Angela Lamarca, Joycelyn J. Lee, Long L. Chan +1 more
Balancing efficacy and toxicity in modern GU cancer therapies: When less is more 14:30–16:00 · Hall 405 — Alison C. Tree, Bryan C. Li, Valerie Huei Li Gan
Small cell lung cancer: Redefining standards of care and emerging therapeutic targets 14:30–16:00 · Hall 406 — Myung-Ju Ahn, Antonio Calles Blanco, Molly Li, Sze Wai Chan
The next wave of precision oncology: What do we do now and where do we go next? 14:30–15:15 · Hall 404 Discussion hub — Valentina Boni, Ya Hwee Tan
Proffered Paper session: Head and neck cancer 16:15–17:45 · Hall 401 — Naomi Kiyota, Juan Li, Paolo Bossi, Muh-Hwa Yang +3 more
Gynaecological sarcomas: Management in Asia & Europe 16:15–17:45 · Room 325 — Jacqueline Ho Sze Lee, Seema Gulia, Matilda Lee, Sabrina Croce
Redefining survivorship in GI cancers 16:15–17:45 · Hall 405 — Stephen L. Chan, Choong-kun Lee, Sara De Dosso, Jeanne Tie +1 more
Development of drugs in the locally advanced setting 16:15–17:45 · Hall 407 — Ben Tran, Iwona Lugowska, Christophe Le Tourneau
Research and development in global oncology 16:15–17:45 · Room 310 — Jia Jenny Liu, Eileen Y. Poon, Emi Noguchi, Jia Zhong
Acral and mucosal melanoma in Asia: A closer look 16:15–17:45 · Hall 402 — Lu Si, Paolo A. Ascierto, Anthony Joshua, Teresa M. Amaral +1 more
Surveillance and prevention of toxicity in breast cancer patients 16:45–17:30 · Hall 404 Discussion hub — Evandro De Azambuja, Shinji Ohno

Day 3 — Sunday 6 December 2026

ESMO Pan-Asian Guidelines Adaptation (PAGA) - Renal cell carcinoma (RCC) 09:00–09:45 · Hall 402 — Ravindran Kanesvaran, Sanjay Popat, Manuela Schmidinger
Rapid Oral session: Gynaecological cancers 09:00–10:30 · Hall 405 — Jung-Yun Lee, Elisa Fontana, Jaya Ghosh, Ning Li +6 more
Understanding the biology of upper GI cancers 09:00–09:45 · Hall 404 Discussion hub — Sun Young Rha
Lung cancer in non-smokers: Emerging insights in biology, risk prediction and management 09:00–10:30 · Room 325 — Derek De-Rui Huang, Herdee Gloriane Luna, Kimiora Henare
Research and development of oncology therapeutics: Breakthroughs in science, shifts in mindset 09:00–10:30 · Hall 401 — Brigette B. Ma, Christopher J Sweeney, Lili Mao
Optimal supportive care for patients on novel therapies 09:00–10:30 · Hall 407 — Herbert Ho Fung Loong, Christina H. Ruhlmann, Marion Subklewe, Tatsunori Shimoi
ESMO Pan-Asian Guidelines Adaptation (PAGA) - Metastatic breast cancer 10:00–10:45 · Hall 402 — Sung-Bae Kim
De-escalation/escalation of therapy for nasopharyngeal carcinoma (NPC): Ready for prime time? 10:45–12:15 · Hall 405 — Mei-Kim Ang, Wan Zamaniah Wan Ishak, Hai-Qiang Mai
Rapid Oral session: Developmental therapeutics and precision medicine 10:45–12:05 · Hall 407 — Humaid O. Al-Shamsi, Daphne Day, Hui Gan, Anwen Xiong +6 more
How to improve diagnostics 10:45–12:15 · Room 325 — Aya El-Helali, Manabu Kinoshita, Zhifeng Shi
Immunotherapy in the clinic now and the next five years 10:45–12:15 · Hall 401 — Jyoti Bajpai, Lavinia Spain, Rienk Offringa, Wee-Joo Chng
ESMO Pan-Asian Guidelines Adaptation (PAGA) - Metastatic colorectal cancer 11:00–11:45 · Hall 402 — Elizabeth Smyth, Hideaki Bando, Sharlene Gill
Multidisciplinary management of oligometastatic NSCLC in clinical practice 11:00–11:45 · Hall 404 Discussion hub — Matthias Guckenberger, Pei Li Stephanie Saw
PeerVoice - Testing. Targeting. Transforming: Practical guidance for the management of HER2-positive gastrointestinal cancers 12:30–14:00 · Hall 402 — Do-Youn Oh, Kohei Shitara, Jeanne Tie, Tony K. Lim
Abbott - Rethinking ES-SCLC: Scientific evidence, biomarkers and the path forward 12:30–14:00 · NSCLC, Metastatic — Daniel Shao Weng Tan, Jonathan W. Riess, Lucksamon Thamlikitkul
Gilead Sciences - Trop-2 ADCs in HER2-negative mBC: Current evidence and future perspectives in 1L mTNBC 12:30–14:00 · Hall 401 — Yoon-Sim Yap, Hope S. Rugo
AstraZeneca - Driving progress in gastroesophageal cancer care through emerging therapies and precision medicine 12:30–14:00 · Gastrointestinal Tumours, Lower Digestive — Wei Peng Yong, Ming-Huang Chen, Omshree Shetty, Salah-Eddin Al-Batran
YO Mentorship session 2 12:30–13:00 · Hall 404 Discussion hub — Paula G. Franco, Elisa Fontana, Hongcheng Zhu, Jyoti Bajpai +1 more
Rare head and neck cancers: How should we treat sinonasal cancer? 14:15–15:00 · Hall 404 Discussion hub — Carla Van Herpen, Caroline Even, Naomi Kiyota
Personalising treatment in early stage to locally advanced EGFR-mutant NSCLC 14:15–15:45 · Hall 405 — Junko Tanizaki, Kevin L. Chua, Pei-Hsing Chen, Sherilyn Liew +1 more
Multidisciplinary management of non-melanoma skin cancers (NMSC) 14:15–15:45 · Hall 401 — Jia Jenny Liu, Dirk Schadendorf, Dion Forstner, Ines E. Pires da Silva +1 more
Research breakthroughs in sarcomas 14:15–15:45 · Hall 402 — Lu Xie, Hyo Song Kim, Ashish Gulia, Robin L. Jones
Bladder cancer: A paradigm for a multidisciplinary effort 14:15–15:45 · Hall 407 — Alison C. Tree, Ming Chun Poon, Stefanie Zschäbitz, Edmund Chiong +1 more
Rapid Oral session: Supportive and palliative care 14:15–15:50 · Room 325 — Anne Letsch, Mary Antonette G. Ong, Sung Yong Oh, Samuel X. Stevens +8 more

Organisers, sponsors and partners